Theralase Technologies Inc.

C$0.19As of Sun 8 Nov 2026, 12:00 UTC
TSXV:TLTHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (6.81%)
Div yield —
ROE (93.40%)
Medical Devices
Beta (5Y) 0.56
PE TTM —
TSR TTM (9.52%)
Mkt cap C$58.99M
ROIC (55.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.223
17.15%
(59.58%)
Hold 5|1|1|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
15.99%
5.75%
(1.43%)
(4.72%)
Revenue$M
4.144
4.347
4.248
4.178
(3.67%)
(0.15%)
0.19%
(1.98%)
Peers (US$41.76M)
Cap (US$)
PE
19.79M
—
42.33M
—
Capital
TTM
5Y
10Y
Leveragex
0.179
1.183
0.957
EBIT/Intx
1.227
0.222
0.203
Own earn%
(29.54)
(166.06)
(176.98)
Sh yield%
33.09
30.83
33.17
Owners
Insiders/Inst%
1.02
81.08
Short interest%
3.40
SBC / revenue%
1.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
9–15
$1 testx
—
Incr. ROIC%
16